0.34
price down icon10.34%   -0.0392
after-market After Hours: .36 0.02 +5.88%
loading
Immunoprecise Antibodies Ltd stock is traded at $0.34, with a volume of 366.11K. It is down -10.34% in the last 24 hours and up +3.28% over the past month.
See More
Previous Close:
$0.3792
Open:
$0.37
24h Volume:
366.11K
Relative Volume:
0.05
Market Cap:
$15.56M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
-0.717
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
-22.78%
1M Performance:
+3.28%
6M Performance:
-37.33%
1Y Performance:
-76.55%
1-Day Range:
Value
$0.338
$0.40
1-Week Range:
Value
$0.3161
$0.429
52-Week Range:
Value
$0.30
$1.48

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
Name
Immunoprecise Antibodies Ltd
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-09-16
Name
Latest SEC Filings
Name
IPA's Discussions on Twitter

Compare IPA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IPA
Immunoprecise Antibodies Ltd
0.34 15.56M 16.77M -11.87M -5.90M -0.4742
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-02-22 Initiated H.C. Wainwright Buy
Oct-25-21 Initiated The Benchmark Company Buy

Immunoprecise Antibodies Ltd Stock (IPA) Latest News

pulisher
01:49 AM

HC Wainwright Has Bearish Forecast for IPA FY2028 Earnings - Defense World

01:49 AM
pulisher
Apr 02, 2025

ImmunoPrecise Antibodies’ (IPA) “Speculative Buy” Rating Reaffirmed at Benchmark - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target Lowered to $5.00 at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

ImmunoPrecise Antibodies Earnings Call Highlights Growth - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Immunoprecise stock target cut to $5 by H.C. Wainwright - Investing.com Australia

Mar 31, 2025
pulisher
Mar 30, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates - MSN

Mar 30, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... By GuruFocus - Investing.com Canada

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo Finance

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlig - GuruFocus

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024) - Yahoo

Mar 29, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Antibodies Reports Q3 FY25 Financial Results - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - 01Net

Mar 28, 2025
pulisher
Mar 28, 2025

Immunoprecise Antibodies Ltd reports results for the quarter ended January 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

IMMUNOPRECISE ANTIBODIES Earnings Results: $IPA Reports Quarterly Earnings - Nasdaq

Mar 28, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Secures Game-Changing $10M Deal as AI Division Reports 132% Growth - Stock Titan

Mar 28, 2025
pulisher
Mar 27, 2025

A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast - Benzinga

Mar 27, 2025
pulisher
Mar 26, 2025

IMMUNOPRECISE ANTIBODIES Earnings Preview: Recent $IPA Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Immunoprecise Antibodies Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 26, 2025
pulisher
Mar 21, 2025

ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday - Defense World

Mar 21, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies’ (IPA) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 17, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

What's Going On With ImmunoPrecise Stock Thursday?ImmunoPrecise Antibodies (NASDAQ:IPA) - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. - 01Net

Mar 13, 2025
pulisher
Mar 13, 2025

Sector Update: Health Care -March 13, 2025 at 08:52 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies Signs Partnership Deal to Develop Cancer Treatments -March 13, 2025 at 07:55 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies Partners for $10M Cancer Therapeutics Development - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement - Investing.com

Mar 13, 2025
pulisher
Mar 12, 2025

IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025 - 01Net

Mar 12, 2025
pulisher
Mar 11, 2025

ImmunoPrecise Q3 Earnings Postponed: Auditors Request Extra Time for Goodwill Review - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

ImmunoPrecise Antibodies Reschedules Q3 Financial Results Release - TipRanks

Mar 11, 2025
pulisher
Mar 06, 2025

ImmunoPrecise Antibodies (IPA) to Release Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Update - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

ImmunoPrecise Antibodies to Announce Q3 Fiscal 2025 Results - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

AI Antibody Pioneer ImmunoPrecise Sets March 13 Earnings CallWhat's Next for This Biotech Innovator? - StockTitan

Mar 05, 2025
pulisher
Mar 05, 2025

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025 - Yahoo Finance

Mar 05, 2025
pulisher
Feb 27, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Expands AI Leadership with Dr. Kamil Isaev Appointment - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

IPA and Ribopro form mRNA antibody discovery collaboration - Yahoo Finance

Feb 27, 2025
pulisher
Feb 26, 2025

ImmunoPrecise Antibodies appoints Joseph Scheffler interim CFO - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy - 01Net

Feb 26, 2025
pulisher
Feb 26, 2025

ImmunoPrecise & RIBOPRO Partner for AI-Powered Antibody Discovery - Contract Pharma

Feb 26, 2025
pulisher
Feb 26, 2025

ImmunoPrecise Antibodies and RIBOPRO Partner to Revolutionize Antibody Discovery - TipRanks

Feb 26, 2025
pulisher
Feb 24, 2025

ImmunoPrecise Antibodies annonce un remaniement de son équipe de direction - The Hastings Tribune

Feb 24, 2025
pulisher
Feb 24, 2025

ImmunoPrecise Antibodies Announces Key Leadership Changes - Voice Of Alexandria

Feb 24, 2025

Immunoprecise Antibodies Ltd Stock (IPA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Cap:     |  Volume (24h):